Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
iRemedy
AddedFeb 16, 2024
UpdatedJun 18, 2026
iRemedy

iRemedy

Seed

iRemedy: America's preferred healthcare ecommerce marketplace for medical supplies, devices, and SaaS solutions.

HQ
Stuart, FL, US
Founded
2005
Overview
Compare
Fundraising
Employees

iRemedy is a medical company providing medical supplies and personal protective equipment. The company owns and operates iRemedySupply.com, fast emerging as America’s preferred healthcare ecommerce marketplace where healthcare consumers come to buy medical supplies, drugs, devices and technologies. Since its market launch in December 2015, thousands of consumers, physicians, nurses, dentists and enterprise users of iRemedy’s Software as a Service (“SaaS”) healthcare ecommerce solutions have joined the fast growing iRemedy community.

Built from the ground-up by proven healthcare technology experts, the iRemedy platform brings modern ecommerce-driven, cost-reducing solutions to healthcare by delivering the quality, security and end-to-end supply chain management required by the industry, elegantly combining on-line requisitioning, ordering and purchasing with robust back-end inventory management and fulfillment services. iRemedy further enhances its electronic marketplace value proposition with fully integrated, SaaS-enabled tools available to iRemedy’s professional users, including managed supply chain solutions, turnkey remote patient monitoring, drug sample program and product recommendation capabilities.

iRemedy - Similar Companies

Remedial Health logo

Remedial Health

remedial.health

Remedy logo

Remedy

Remedly logo

Remedly

remedly.com

InvoCure logo

InvoCure

invocure.com

Remedify logo

Remedify

remedify.com

Doorbell Health logo

Doorbell Health

Rymedi logo

Rymedi

iMedicare logo

iMedicare

imedicare.com

Epimedica logo

Epimedica

My Own Med logo

My Own Med

myownmed.com

Remède logo

Remède

remedeco.com

DocShop Pro logo

DocShop Pro

docshoppro.com

flipMD logo

flipMD

Remedi SeniorCare logo

Remedi SeniorCare

remedirx.com

Supply Clinic logo

Supply Clinic

supplyclinic.com

iRemedy - Quick Facts

Who are iRemedy's competitors?

Companies similar to iRemedy include Remedial Health, Remedy, Remedly and InvoCure.

When was iRemedy founded?

iRemedy was founded in 2005.

Where is iRemedy's headquarters located?

iRemedy's headquarters is located in Stuart, FL, US.

When was iRemedy's last funding round?

iRemedy's most recent funding round was for $1M (USD) in May 2020.

How much has iRemedy raised to-date?

As of May 19, 2020, iRemedy has raised a total of $4.2M (USD).

How many employees does iRemedy have?

iRemedy has 40 employees as of Feb 4, 2024.

iRemedy - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Ecommerce
  • Marketplace
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
  • Enterprise
  • Small Business
Main Product
  • Medical Supplies
  • SaaS
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software